Hikma Pharmaceuticals – Hot or Not

Hikma Pharmaceuticals (LSE-London:HIK) was founded in Jordan and is now mostly a multinational generic pharmaceutical manufacturer. It has a market cap of GBP 4.1 billion, a PE of 33.5 and a dividend yield of 1.51 per cent. Guest Jean Pierre Verster from Fairtree Capital and resident expert Paul Theron from Vestact decide whether Hikma Pharmaceuticals is hot or not.

Leave a Comment